Back to Search
JOANNA-GRACE MANZANO, M.D.
M.D.
Internal Medicine Physician
NPI: 1578837878IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
P6026(TX)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 2003
Research & Publications (20)
Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR).
PMID 19195847·Eur Psychiatry·2009
4-observational
Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancer.
PMID 19139129·Mol Cancer Ther·2009
8-other
A proteomic approach links decreased pyruvate kinase M2 expression to oxaliplatin resistance in patients with colorectal cancer and in human cell lines.
PMID 19372549·Mol Cancer Ther·2009
8-other
Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma.
PMID 19186051·Eur J Cancer·2009
3-trial
Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin-based chemotherapy.
PMID 19296535·Int J Cancer·2009
8-other
Cisplatin plus weekly CPT-11/docetaxel in advanced esophagogastric cancer: a phase I study with pharmacogenetic assessment of XPD, XRCC3 and UGT1A1 polymorphisms.
PMID 18335219·Cancer Chemother Pharmacol·2008
3-trial
Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer.
PMID 18448328·Eur J Cancer·2008
3-trial
Bisursodeoxycholate(ethylenediamine)platinum(II): a new autofluorescent compound. Cytotoxic activity and cell cycle analysis in ovarian and hematological cell lines.
PMID 18985248·Dalton Trans·2008
8-other
Colorectal cancer metastasis resectability after treatment with the combination of oxaliplatin, irinotecan and 5-fluorouracil. Final results of a phase II study.
PMID 17957505·Acta Oncol·2008
3-trial
[Why is it essential to diagnose and prevent postpartum depression?].
PMID 17564349·Rev Med Suisse·2007
6-review
Influence of thyroid hormone and thyroid hormone receptors in the generation of cerebellar gamma-aminobutyric acid-ergic interneurons from precursor cells.
PMID 17761765·Endocrinology·2007
7-preclinical
In-vitro renal shrinkage after hypertonic saline perfusion for organ removal during laparoscopic nephrectomy.
PMID 17867948·J Endourol·2007
7-preclinical
New fluorescent antitumour cisplatin analogue complexes. Study of the characteristics of their binding to DNA by flow injection analysis.
PMID 17557196·J Fluoresc·2007
8-other
Influence of thyroid hormones on maturation of rat cerebellar astrocytes.
PMID 17408906·Int J Dev Neurosci·2007
7-preclinical
Early intervention with epoetin beta prevents severe anaemia in patients with solid tumours receiving platinum-based chemotherapy: results of the NeoPrevent study.
PMID 16874498·Cancer Chemother Pharmacol·2007
3-trial
Combined analysis of genetic polymorphisms in thymidylate synthase, uridine diphosphate glucoronosyltransferase and X-ray cross complementing factor 1 genes as a prognostic factor in advanced colorectal cancer patients treated with 5-fluorouracil plus oxaliplatin or irinotecan.
PMID 17273745·Oncol Rep·2007
8-other
Weekly docetaxel with concomitant radiotherapy in patients with inoperable oesophageal cancer.
PMID 17403629·Clin Transl Oncol·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1578837878
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 23
- Publications
- 20
Are you this provider?
Claim Your Profile